These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23812858)

  • 1. United States women receive more curative treatment for hepatocellular carcinoma than men.
    Cauble S; Abbas A; Balart L; Bazzano L; Medvedev S; Shores N
    Dig Dis Sci; 2013 Oct; 58(10):2817-25. PubMed ID: 23812858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of metastatic hepatocellular carcinoma, a nationwide perspective.
    Abbas A; Medvedev S; Shores N; Bazzano L; Dehal A; Hutchings J; Balart L
    Dig Dis Sci; 2014 Nov; 59(11):2813-20. PubMed ID: 24903653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients With Hepatocellular Carcinoma Have Highest Rates of Wait-listing for Liver Transplantation Among Patients With End-Stage Liver Disease.
    Goldberg D; French B; Newcomb C; Liu Q; Sahota G; Wallace AE; Forde KA; Lewis JD; Halpern SD
    Clin Gastroenterol Hepatol; 2016 Nov; 14(11):1638-1646.e2. PubMed ID: 27374003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of geographic disparity on liver allocation for hepatocellular cancer in the United States.
    Kadry Z; Schaefer EW; Uemura T; Shah AR; Schreibman I; Riley TR
    J Hepatol; 2012 Mar; 56(3):618-25. PubMed ID: 22027581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular Carcinoma Is the Most Common Indication for Liver Transplantation and Placement on the Waitlist in the United States.
    Yang JD; Larson JJ; Watt KD; Allen AM; Wiesner RH; Gores GJ; Roberts LR; Heimbach JA; Leise MD
    Clin Gastroenterol Hepatol; 2017 May; 15(5):767-775.e3. PubMed ID: 28013117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of socioeconomics, surgical therapy, and survival of early stage hepatocellular carcinoma.
    Peters NA; Javed AA; He J; Wolfgang CL; Weiss MJ
    J Surg Res; 2017 Apr; 210():253-260. PubMed ID: 28457336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Race/Ethnicity-specific Disparities in Hepatocellular Carcinoma Stage at Diagnosis and its Impact on Receipt of Curative Therapies.
    Ha J; Yan M; Aguilar M; Tana M; Liu B; Frenette CT; Bhuket T; Wong RJ
    J Clin Gastroenterol; 2016; 50(5):423-30. PubMed ID: 26583267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver transplantation for T3 lesions has higher waiting list mortality but similar survival compared to T1 and T2 lesions.
    Schmitt TM; Kumer SC; Shah N; Argo CK; Northup PG
    Ann Hepatol; 2010; 9(4):390-6. PubMed ID: 21057157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Women receive more inpatient resections and ablations for hepatocellular carcinoma than men.
    Sobotka L; Hinton A; Conteh L
    World J Hepatol; 2017 Dec; 9(36):1346-1351. PubMed ID: 29359018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric liver transplantation for hepatocellular cancer and rare liver malignancies: US multicenter and single-center experience (1981-2015).
    Vinayak R; Cruz RJ; Ranganathan S; Mohanka R; Mazariegos G; Soltys K; Bond G; Tadros S; Humar A; Marsh JW; Selby RR; Reyes J; Sun Q; Haberman K; Sindhi R
    Liver Transpl; 2017 Dec; 23(12):1577-1588. PubMed ID: 28834194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence of hepatocellular cancer after liver transplantation: the role of primary resection and salvage transplantation in East and West.
    Lai Q; Avolio AW; Lerut J; Singh G; Chan SC; Berloco PB; Tisone G; Agnes S; Chok KS; Sharr W; Rossi M; Manzia TM; Lo CM
    J Hepatol; 2012 Nov; 57(5):974-9. PubMed ID: 22771712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial disparities in utilization of liver transplantation for hepatocellular carcinoma in the United States, 1998-2002.
    Siegel AB; McBride RB; El-Serag HB; Hershman DL; Brown RS; Renz JF; Emond J; Neugut AI
    Am J Gastroenterol; 2008 Jan; 103(1):120-7. PubMed ID: 18005365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: the national experience.
    Schwartz JJ; Pappas L; Thiesset HF; Vargas G; Sorensen JB; Kim RD; Hutson WR; Boucher K; Box T
    Liver Transpl; 2012 Apr; 18(4):423-33. PubMed ID: 22250078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver transplantation for fibrolamellar hepatocellular carcinoma: A national perspective.
    Atienza LG; Berger J; Mei X; Shah MB; Daily MF; Grigorian A; Gedaly R
    J Surg Oncol; 2017 Mar; 115(3):319-323. PubMed ID: 27878821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are hepatocellular carcinoma patients more likely to receive liver resection in regions with longer transplant wait times?
    Anderson JE; Hemming AW; Chang DC; Talamini MA; Mekeel KL
    Transplant Proc; 2014; 46(1):199-201. PubMed ID: 24507051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed hepatocellular carcinoma model for end-stage liver disease exception score improves disparity in access to liver transplant in the United States.
    Heimbach JK; Hirose R; Stock PG; Schladt DP; Xiong H; Liu J; Olthoff KM; Harper A; Snyder JJ; Israni AK; Kasiske BL; Kim WR
    Hepatology; 2015 May; 61(5):1643-50. PubMed ID: 25644186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The race to liver transplantation: a comparison of patients with and without hepatocellular carcinoma from listing to post-transplantation.
    Patel MS; Kohn R; Kratz JR; Shah JA; Markmann JF; Vagefi PA
    J Am Coll Surg; 2015 Jun; 220(6):1001-7. PubMed ID: 25868408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validating posttransplant hepatocellular carcinoma recurrence data in the United Network for Organ Sharing database.
    Samoylova ML; Dodge JL; Vittinghoff E; Yao FY; Roberts JP
    Liver Transpl; 2013 Dec; 19(12):1318-23. PubMed ID: 24039140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of obesity on in-hospital and postoperative outcomes of hepatic resection for malignancy: a 10-year retrospective analysis from the US National Inpatient Sample.
    He J; Liu H; Deng L; Wei X; Chen T; Xia S; Liu Y
    BMJ Open; 2019 Aug; 9(8):e029823. PubMed ID: 31462479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing disparity in waitlist mortality rates with increased model for end-stage liver disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma.
    Goldberg D; French B; Abt P; Feng S; Cameron AM
    Liver Transpl; 2012 Apr; 18(4):434-43. PubMed ID: 22271656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.